ProShares Ultra Nasdaq Biotechnology (BIB)
120.91
-1.25
(-1.03%)
USD |
NASDAQ |
Aug 24, 16:00
120.77
-0.14
(-0.11%)
Pre-Market: 09:03
Price Chart
Key Stats
| Net Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.95% | 0.06% | 102.71M | 10860.33 |
| Weighted Average Dividend Yield | Turnover Ratio (Generic) | 1 Year Fund Level Flows | Max Drawdown (Since Inception) |
| 0.72% | 28.00% | -16.91M |
Basic Info
| Investment Strategy | |
| The Fund seeks daily investment results, before fees and expenses, that correspond to two times the return of the Nasdaq Biotechnology Index. The Index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Multi Cap Growth |
| Broad Asset Class | Miscellaneous |
| Broad Category | Alternative Strategies |
| Global Peer Group | Alternative Equity Leveraged |
| Peer Group | Equity Leverage Funds |
| Global Macro | Alternative Equity |
| US Macro | Large-Cap Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Equity Leverage Funds |
| Fund Owner Firm Name | ProShares |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of August 25, 2026.
Asset Allocation
As of July 31, 2026.
| Type | % Net |
|---|---|
| Cash | 37.22% |
| Stock | 55.98% |
| Bond | 6.40% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 0.40% |
Basic Info
| Investment Strategy | |
| The Fund seeks daily investment results, before fees and expenses, that correspond to two times the return of the Nasdaq Biotechnology Index. The Index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Multi Cap Growth |
| Broad Asset Class | Miscellaneous |
| Broad Category | Alternative Strategies |
| Global Peer Group | Alternative Equity Leveraged |
| Peer Group | Equity Leverage Funds |
| Global Macro | Alternative Equity |
| US Macro | Large-Cap Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Equity Leverage Funds |
| Fund Owner Firm Name | ProShares |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |